Capital Guardian Trust’s Kite Pharma, Inc. KITE Stock Holding History

Capital Guardian Trust’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-400	Closed	-$72K	–	303
2017 Q3	$72K	Sell	400 -458,100	-100%	-$63.8M	﹤0.01%	198
2017 Q2	$47.5M	Sell	458,500 -2,200	-0.5%	-$180K	0.87%	45
2017 Q1	$36.2M	Sell	460,700 -3,000	-0.6%	-$186K	0.27%	114
2016 Q4	$20.8M	Sell	463,700 -7,600	-2%	-$373K	0.16%	132
2016 Q3	$26.3M	Buy	471,300 +21,100	+5%	+$1.18M	0.2%	132
2016 Q2	$22.5M	Sell	450,200 -1,500	-0.3%	-$73.7K	0.17%	136
2016 Q1	$20.7M	Sell	451,700 -5,900	-1%	-$286K	0.16%	138
2015 Q4	$28.2M	Sell	457,600 -13,000	-3%	-$915K	0.22%	129
2015 Q3	$26.2M	Sell	470,600 -19,600	-4%	-$1.23M	0.21%	130
2015 Q2	$29.9M	Sell	490,200 -6,100	-1%	-$348K	0.22%	131
2015 Q1	$28.6M	Buy	496,300 +5,500	+1%	+$369K	0.21%	129
2014 Q4	$28.3M	Buy	+490,800	New	+$20.7M	0.2%	119

Capital Guardian Trust's KITE Position: Q4 2017 in Review

Capital Guardian Trust sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 400 shares — an estimated $72K sold.

Capital Guardian Trust first reported a position in KITE in Q4 2014 and held it in 12 quarters. The position peaked at $47.5M in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Capital Guardian Trust reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Capital Guardian Trust sold 400 Kite Pharma, Inc. shares in Q4 2017, an estimated $72K.
Capital Guardian Trust first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 12 quarters.
Capital Guardian Trust's Kite Pharma, Inc. position peaked at $47.5M in Q2 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Capital Guardian Trust's 13F filing for Q4 2017, filed 14 Feb 2018.